| Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465) |
|---|
| 08/11/2004 | EP1444210A1 Qunazoline derivatives as antitumor agents |
| 08/05/2004 | WO2004065380A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 08/05/2004 | CA2512899A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 08/04/2004 | CN1517347A Antivirus nucleoside derivative |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/03/2004 | CA2070230C Crystalline oxathiolane derivatives |
| 07/29/2004 | WO2004063191A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 07/29/2004 | CA2512184A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/08/2004 | US20040133005 Process for preparing substituted pyridnes |
| 07/01/2004 | US20040127552 Benzoaxathiepin derivatives and their use as medicines |
| 06/30/2004 | EP1113802B1 Antiviral combinations of lamivudine and adefovir |
| 06/23/2004 | CN1154500C Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition |
| 06/22/2004 | US6752929 Methods of separating FTC isomers and derivatives thereof |
| 06/16/2004 | CN1505623A Benzoaxathiepin derivatives and their use as medicines |
| 06/15/2004 | US6750213 Bone disorders; urogenital system disorders; anticancer agents |
| 06/10/2004 | WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/10/2004 | CA2502970A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/09/2004 | CN1503796A Polymorphic and other crystalling forms of cis-ftc |
| 06/09/2004 | CN1503795A Water-soluble triazole fungicide |
| 06/09/2004 | CN1152876C Substituted phenyl uracils compound |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | CN1500782A Process for the diastereoselective synthesis of nucleoside analogues |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 05/27/2004 | US20040102592 As monomer to produce acrylic polymer |
| 05/26/2004 | EP1421949A1 Hepatitis b virus proliferation inhibitor |
| 05/26/2004 | CN1151146C Process for diastereoselective synthesis of nucleoside analogues |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/13/2004 | WO2004039799A1 Cyclopropyl-thienyl-carboxamide as fungicides |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | CN1495180A Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 04/28/2004 | EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 04/28/2004 | EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/28/2004 | CN1492857A Improved compounds for generating chemiluminescence with peroxidase |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/20/2004 | US6723728 Polymorphic and other crystalline forms cis-FTC |
| 04/14/2004 | EP1406896A1 Atereoselective method for the preparation of nucleoside analogues |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063756 Administering a therapeutically effective amount of 2-Aminoquinolines for the prevention or treatment of eating disorders, weight gain and obesity |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/24/2004 | CN1142929C Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene |
| 03/18/2004 | US20040053943 Novel compounds |
| 03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | CN1141305C Manufacture of 1, 3-oxathiolane nucleosides |
| 03/09/2004 | US6703396 Cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl) -(1h)-pyrimidin-2-one |
| 03/04/2004 | WO2004018438A2 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 03/04/2004 | US20040044226 Estrogen receptor modulators |
| 03/04/2004 | CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | US20040038350 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/18/2004 | EP1389207A1 Polymorphic and other crystalline forms of cis-ftc |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/11/2004 | EP1388540A1 Acrylic esters and use thereof |
| 02/10/2004 | US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | US20040019051 Eating disorders of a disturbed or impaired fundus such as dyspepsia, early satiety, bloating and anorexia; e.g.,1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/22/2004 | US20040014967 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/21/2004 | EP1382343A1 Combination therapy to treat hepatitis B virus |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/14/2004 | EP1380303A1 Combination therapy to treat hepatitis B virus |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | CN1465574A L-nucleoside derivative and use thereof |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 12/31/2003 | WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/30/2003 | US6670480 Process for preparing substituted pyridines |
| 12/24/2003 | WO2003105850A1 2-aminoquinolines as melanin concentrating hormone receptor antagonists |
| 12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 12/17/2003 | EP1370547A1 Benzoaxathiepin derivatives and their use as medicines |
| 12/17/2003 | CN1462272A Acrylic esters compound and use thereof |
| 12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/04/2003 | US20030225132 Heterocyclic salts such as 3-(3-Hydroxyphenyl)-2-(4-(2-(1-pyrrolidinium)ethoxyphenol)-2,3-dihydro-1,4 -benzoxathiin-6-ol hydrochloride salt, used as estrane agonists, for phrophylaxis of bone disorders |
| 11/27/2003 | WO2003097605A1 Pesticidal pyridinecarboxamide derivatives |
| 11/26/2003 | EP1364336A2 Autogrid analysis |
| 11/19/2003 | EP1362856A1 Water-soluble triazole fungicide |
| 11/18/2003 | US6649618 Substituted amidoalkyl-uracils and their use |
| 11/12/2003 | EP1361223A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 11/12/2003 | EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 11/12/2003 | EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators |
| 11/11/2003 | US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 11/11/2003 | CA2113424C Muscarinic agonists |
| 11/06/2003 | WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 11/06/2003 | WO2003091239A1 Estrogen receptor modulators |